Medical illustration of the liver and pancreas alongside text announcing MHRA approval of Ziihera for HER2-positive biliary tract cancer. Biliary Cancer
  • DrugsArea™
  • Posted by DrugsArea™
February 20, 2026

Biliary Cancer Breakthrough: MHRA Approves Zanidatamab (Ziihera) A Major Win in the...

Read More

Welcome to DrugsArea™. Please note that all information provided on this website is for educational and informational purposes only. It is not intended to replace professional medical advice, diagnosis, or treatment.